1. Home
  2. ALTI vs CADL Comparison

ALTI vs CADL Comparison

Compare ALTI & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AlTi Global Inc.

ALTI

AlTi Global Inc.

HOLD

Current Price

$2.94

Market Cap

409.8M

Sector

Finance

ML Signal

HOLD

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$8.54

Market Cap

578.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALTI
CADL
Founded
2020
1999
Country
United States
United States
Employees
490
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
409.8M
578.8M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
ALTI
CADL
Price
$2.94
$8.54
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$19.00
AVG Volume (30 Days)
220.8K
1.6M
Earning Date
05-11-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
41.11
58.62
EPS
N/A
N/A
Revenue
$254,956,000.00
$125,000.00
Revenue This Year
$18.06
N/A
Revenue Next Year
$10.71
N/A
P/E Ratio
N/A
N/A
Revenue Growth
23.21
N/A
52 Week Low
$2.75
$4.35
52 Week High
$5.45
$9.57

Technical Indicators

Market Signals
Indicator
ALTI
CADL
Relative Strength Index (RSI) 40.39 55.87
Support Level N/A $4.80
Resistance Level $3.93 $9.42
Average True Range (ATR) 0.18 0.61
MACD 0.01 -0.10
Stochastic Oscillator 25.76 37.20

Price Performance

Historical Comparison
ALTI
CADL

About ALTI AlTi Global Inc.

AlTi Global Inc is a wealth and investment partner to families, foundations, and institutions, helping clients activate capital, bring structure to complexity, and plan across borders and generations. The company combines the breadth of an international firm with the service offering of a family office to deliver solutions for wealth and capital. It provides services including discretionary and non-discretionary investment advisory, estate and wealth planning, trust and fiduciary, governance, philanthropy, and family office services, along with access to alternative investment opportunities. The company generates revenue from management, advisory, trustee, or administration fees, performance or incentive fees, distributions from investments, and other income or fees.

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Share on Social Networks: